| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/03/2005 | EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors |
| 08/03/2005 | EP1142890B1 Aminopyrazole derivatives |
| 08/03/2005 | EP1141111B1 Gel compositions |
| 08/03/2005 | EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/03/2005 | CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/03/2005 | CN1650005A Antimicrobial polypeptide and utizliation thereof |
| 08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/03/2005 | CN1649884A Novel azacyclic ethynyl derivatives |
| 08/03/2005 | CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 08/03/2005 | CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 08/03/2005 | CN1649871A Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6, 7, 8, 9-tetrahydropydimido[1, 2-a]pyrimidin-4-one derivatives |
| 08/03/2005 | CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 08/03/2005 | CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649853A Thiazolidinones compound, its preparing method and use as medicine |
| 08/03/2005 | CN1649849A Tachykinin receptor antagonists |
| 08/03/2005 | CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF) |
| 08/03/2005 | CN1649846A Compounds of the family of 3-alkyl-(4, 5-diphenyl-imidazol-1-yl) and their use as soothing agents |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 08/03/2005 | CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient |
| 08/03/2005 | CN1649819A Novel thyroid receptor ligands |
| 08/03/2005 | CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| 08/03/2005 | CN1649603A Aqueous compositions containing metronidazole |
| 08/03/2005 | CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 08/03/2005 | CN1649597A Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
| 08/03/2005 | CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 08/03/2005 | CN1649584A Antibacterial compositions comprising metal phthalocyanine analogues |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 08/03/2005 | CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 08/03/2005 | CN1649551A Drug-delivery endovascular stent and method for treating restenosis |
| 08/03/2005 | CN1647818A External essence oil for treating beriberi |
| 08/03/2005 | CN1647815A Product with protective function to radiation hazard |
| 08/03/2005 | CN1647811A Medicnial liquid and technology for one step removing freckle, chloasma and senile plague |
| 08/03/2005 | CN1647807A Plaster special for carbuncle, cellulitis, sore, furuncle and pile and its preparing method |
| 08/03/2005 | CN1647804A External medicine spray |
| 08/03/2005 | CN1647802A External use article for skin |
| 08/03/2005 | CN1647798A Disposable bleaching water for removing black nevus and black nevus removing technology |
| 08/03/2005 | CN1647701A Method for producing soybean trypsin inhibitor concentration |
| 08/03/2005 | CN1213047C Puring derivatives inhibitors of tyrosine kinase SYK |
| 08/03/2005 | CN1213045C Tyrosine kinase inhibitors |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/03/2005 | CN1213017C Propynyl or diene diaryl compounds |
| 08/03/2005 | CN1212853C Pilatory |
| 08/03/2005 | CN1212826C Topically applied idebenone-containing agent with protective and regenerative effect |
| 08/02/2005 | US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 08/02/2005 | US6924314 Compounds for the treatment of metabolic disorders |
| 08/02/2005 | US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases |
| 08/02/2005 | US6924305 Diazocine derivatives and their use as tryptase inhibitors |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924288 Enantiomerically pure opioid diarylmethylpiperzine and methods of using same |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 08/02/2005 | CA2332538C Novel 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 08/02/2005 | CA2326528C Cholesterol sulfate compositions for artificial skin tanning |
| 08/02/2005 | CA2264094C Structured water for enhanced moisturization |
| 08/02/2005 | CA2186011C Mild antimicrobial liquid cleaning formulations |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
| 07/28/2005 | US20050165116 ketones carrying electron withdrawing substituents alpha to the carbonyl functionality; phospholipase A2 inhibitor; potent in reducing eicosanoid production |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165033 mediated by prostaglandin D2, a ligand for orphan receptor CRTH2; rhinitis; N-substituted by a benzothiazolyl, a pyrimidinyl, an imidazolyl, an oxazolyl, or a thiazolyl |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164993 Methods of treating allergic reactions |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050163878 Therapeutic agent of skin diseases |
| 07/28/2005 | US20050163863 use of arsenic for treating autoimmune diseases, in particular autoimmune lymphoproliferative syndrome |
| 07/28/2005 | US20050163786 Compounds and methods for modulating adhesion molecule function |
| 07/28/2005 | DE10359384A1 Verwendung eines Extraktes von Aloysia triphylla als Matrixprotektor Use of an extract of Aloysia triphylla as a matrix protector |
| 07/28/2005 | DE10359153A1 Use of specific triterpene derivatives for systemic treatment of light-induced dermatatis and the long-term consequences of exposure to ultra-violet light |
| 07/28/2005 | CA2553953A1 Therapeutic use of quinonoid derivatives of cannabinoids |
| 07/28/2005 | CA2553334A1 Preparation of fibroblast-populated connective tissue substitute |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557167A1 Viral inhibition by long-chain alcohols alkanes fatty acids and amides |
| 07/27/2005 | EP1556488A2 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/27/2005 | EP1556410A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556140A2 Novel compounds |
| 07/27/2005 | EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |